Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of sufugolix versus leuprorelin in symptomatic endometriosis
2004-001720-21Phase 3Unknown
- Sponsor
- Takeda
- Start
- Jul 2005
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sufugolix and leuprolide in endometriosis (3 arms), sponsored by Takeda. Primary endpoints: Symptomatic improvement rate in dysmenorrhea and Symptomatic improvement rate in pelvic pain. Status: unknown.
02
Drugs
sufugolixleuprolide
03
Conditions
endometriosis
Beyond the preview
Go deeper on 2004-001720-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001720-21.